Sunesis Pharmaceuticals to Present at Cowen & Co. 26th Annual Health Care Conference
04 March 2006 - 12:00AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., March 3 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
Daniel N. Swisher, Jr., President and Chief Executive Officer, will
present a company update at the Cowen & Co. 26th Annual Health
Care Conference in Boston, MA on March 7, 2006 at 8:50 a.m. local
time. Interested parties may access the webcast of the presentation
by visiting the Sunesis website at http://ir.sunesis.com/ . A
replay of the webcast will be archived on the "Calendar of Events"
page in the Investors and Media section of the Sunesis website for
two weeks until March 23, 2006. About Sunesis Pharmaceuticals
Sunesis is a clinical-stage biopharmaceutical company focused on
the discovery, development and commercialization of novel small
molecule therapeutics for oncology and other serious diseases.
Sunesis has built a broad product candidate portfolio through
internal discovery and in-licensing of novel cancer therapeutics.
Sunesis is advancing its product candidates through in-house
research and development efforts and strategic collaborations with
leading pharmaceutical and biopharmaceutical companies. For further
information on Sunesis Pharmaceuticals, please visit
http://www.sunesis.com/ . Forward-Looking Statements This press
release may contain forward-looking statements that involve
substantial risks and uncertainties. Sunesis may not actually
achieve the plans, intentions or expectations contained in such
forward-looking statements. Actual results or events could differ
materially from the plans, intentions and expectations contained in
such forward-looking statements. Sunesis does not assume any
obligation to update any such forward-looking statements.
DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT: investors, Eric
Bjerkholt, CFO of Sunesis Pharmaceuticals, Inc., +1-650-266-3717,
or media, Karen L. Bergman, +1-650-575-1509, or Michelle Corral,
+1-415-794-8662, both of BCC Partners, for Sunesis Pharmaceuticals,
Inc. Web site: http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals (MM) News Articles